Overview
ARA-290, also known as cibinetide, is an 11-amino-acid peptide derived from erythropoietin research. It was engineered to activate tissue-protective pathways without stimulating red blood cell production in the same way as erythropoietin. This distinction is central to understanding the compound.
ARA-290 is most commonly discussed in small fiber neuropathy, tissue-protection, inflammation, and innate repair receptor research. Human studies have evaluated it in conditions such as sarcoidosis-associated small fiber neuropathy and diabetic small fiber neuropathy.
ARA-290 is best understood as a tissue-protective and neuropathy research peptide rather than a general recovery peptide. Its erythropoietin-derived background, innate repair receptor mechanism, and human neuropathy studies define the main scientific context.